Literature DB >> 34159396

Cutaneous Expression of Familial Cancer Syndromes.

Anne-Johanne Andersen1, Juliane Schierbeck, Anette Bygum, Nieves Puente-Pablo.   

Abstract

Genodermatoses are inherited syndromes with cutaneous manifestations. Some genodermatoses are associated with malignancy of internal organs and tissues. Early detection of the typical signs of these syndromes is important, because those lesions are a sign of underlying predisposition to extracutaneous neoplasms. The dermatologist has an important role in the early detection of these signs and syndromes, as early detection may affect the clinical course of the disease. We report here the characteristic cutaneous findings that dermatologists should be aware of in order to identify a genodermatosis with a possible associated malignancy. An updated overview of the pathogenesis and clinical findings of these syndromes is provided. Furthermore, surveillance protocols and treatment recommendations are explored.

Entities:  

Keywords:  cutaneous lesions; familial cancer; genetic predisposition; hereditary neoplastic syndromes; skin diseases; genodermatoses

Mesh:

Year:  2021        PMID: 34159396      PMCID: PMC9413656          DOI: 10.2340/00015555-3852

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   3.875


  89 in total

1.  [Besnier's eruptive leiomyoma].

Authors:  P BLUM; L JEAN
Journal:  Bull Soc Fr Dermatol Syphiligr       Date:  1954 Jul-Oct

2.  Tuberous sclerosis complex and its founders.

Authors:  F E Jansen; O van Nieuwenhuizen; A C van Huffelen
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-05       Impact factor: 10.154

Review 3.  Bazex-Dupré-Christol syndrome: review of clinical and molecular aspects.

Authors:  Manahel M AlSabbagh; Mariam A Baqi
Journal:  Int J Dermatol       Date:  2018-05-28       Impact factor: 2.736

4.  Cutaneous leiomyomata with uterine leiomyomata.

Authors:  W B Reed; R Walker; R Horowitz
Journal:  Acta Derm Venereol       Date:  1973       Impact factor: 4.437

Review 5.  Targeting HIF-1 for cancer therapy.

Authors:  Gregg L Semenza
Journal:  Nat Rev Cancer       Date:  2003-10       Impact factor: 60.716

6.  Empirical development of improved diagnostic criteria for neurofibromatosis 2.

Authors:  Michael E Baser; Jan M Friedman; Harry Joe; Andrew Shenton; Andrew J Wallace; Richard T Ramsden; D Gareth R Evans
Journal:  Genet Med       Date:  2011-06       Impact factor: 8.822

Review 7.  Xeroderma pigmentosum.

Authors:  Alan R Lehmann; David McGibbon; Miria Stefanini
Journal:  Orphanet J Rare Dis       Date:  2011-11-01       Impact factor: 4.123

Review 8.  Ataxia telangiectasia: a review.

Authors:  Cynthia Rothblum-Oviatt; Jennifer Wright; Maureen A Lefton-Greif; Sharon A McGrath-Morrow; Thomas O Crawford; Howard M Lederman
Journal:  Orphanet J Rare Dis       Date:  2016-11-25       Impact factor: 4.123

9.  Neurofibromatosis 1 French national guidelines based on an extensive literature review since 1966.

Authors:  Christina Bergqvist; Amandine Servy; Laurence Valeyrie-Allanore; Salah Ferkal; Patrick Combemale; Pierre Wolkenstein
Journal:  Orphanet J Rare Dis       Date:  2020-02-03       Impact factor: 4.123

10.  Legius Syndrome and its Relationship with Neurofibromatosis Type 1.

Authors:  Ellen Denayer; Eric Legius
Journal:  Acta Derm Venereol       Date:  2020-03-25       Impact factor: 3.875

View more
  1 in total

Review 1.  Genodermatoses - Opportunities for Early Detection and Cancer Prevention.

Authors:  Helena Carley; Anjana Kulkarni
Journal:  Curr Genet Med Rep       Date:  2022-10-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.